OpenBilldrug price receipt

NADAC week of 2026-10-14

BACLOFEN 20 MG TABLET

For 30 tablets

Pharmacies pay

$1.56 filed

30 × $0.05185 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$5.60 filed

30 × $0.18654 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

3.6× estimated

Medicare paid 3.6× what pharmacies pay.

Part D averages every strength and form sold under “Baclofen*” / “Baclofen” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$6.79 estimated

$1.56 + $0.23 (15%) + $5.00 fee per fill = $6.79

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

BACLOFEN 20 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as baclofen.

FDA gives its dosage form as tablet and its route as oral.

FDA lists 17 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Lannett Company, Inc. and Par Health USA, LLC.

FDA’s Established Pharmacologic Class for it is gamma-Aminobutyric Acid-ergic Agonist.

The NADAC file of 2026-10-14 prices it under 47 NDCs (National Drug Codes); the FDA directory lists 41 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1.56 for 30 tablets (30 × $0.05185 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 17 labelers

LabelerNDCsPharmacies pay per unit
Method Pharmaceuticals LLC4$0.05185 per EA filed
Advagen Pharma Limited3$0.05185 per EA filed
Aurobindo Pharma Limited3$0.05185 per EA filed
Lannett Company, Inc.3$0.05185 per EA filed
Lifestar Pharma LLC3$0.05185 per EA filed
Rising Pharma Holdings, Inc.3$0.05185 per EA filed
TruPharma LLC3$0.05185 per EA filed
Zydus Pharmaceuticals (USA) Inc.3$0.05185 per EA filed
Chartwell RX, LLC2$0.05185 per EA filed
Eywa Pharma Inc2$0.05185 per EA filed
Major Pharmaceuticals2$0.05185 per EA filed
Northstar RxLLC2$0.05185 per EA filed
Par Health USA, LLC2$0.05185 per EA filed
Teva Pharmaceuticals USA, Inc.2$0.05185 per EA filed
Unichem Pharmaceuticals (USA), Inc.2$0.05185 per EA filed
American Health Packaging1$0.05185 per EA filed
AvPAK1$0.05185 per EA filed
Not listed as a package in the FDA directory6$0.05185 per EA filed
All 47 NDCs, with labeler and price
  • 00172-4097-60 · Teva Pharmaceuticals USA, Inc. · $0.05185 per EA · eff. 2026-09-23 filed
  • 00172-4097-80 · Teva Pharmaceuticals USA, Inc. · $0.05185 per EA · eff. 2026-09-23 filed
  • 00527-1337-01 · Lannett Company, Inc. · $0.05185 per EA · eff. 2026-09-23 filed
  • 00527-1337-05 · Lannett Company, Inc. · $0.05185 per EA · eff. 2026-09-23 filed
  • 00527-1337-10 · Lannett Company, Inc. · $0.05185 per EA · eff. 2026-09-23 filed
  • 00603-2407-21 · Par Health USA, LLC · $0.05185 per EA · eff. 2026-09-23 filed
  • 00603-2407-28 · Par Health USA, LLC · $0.05185 per EA · eff. 2026-09-23 filed
  • 00904-6476-61 · Major Pharmaceuticals · $0.05185 per EA · eff. 2026-09-23 filed
  • 00904-7553-61 · Major Pharmaceuticals · $0.05185 per EA · eff. 2026-09-23 filed
  • 16571-0172-01 · Rising Pharma Holdings, Inc. · $0.05185 per EA · eff. 2026-09-23 filed
  • 16571-0172-10 · Rising Pharma Holdings, Inc. · $0.05185 per EA · eff. 2026-09-23 filed
  • 16571-0172-50 · Rising Pharma Holdings, Inc. · $0.05185 per EA · eff. 2026-09-23 filed
  • 16714-0072-04 · Northstar RxLLC · $0.05185 per EA · eff. 2026-09-23 filed
  • 16714-0072-05 · Northstar RxLLC · $0.05185 per EA · eff. 2026-09-23 filed
  • 29300-0344-01 · Unichem Pharmaceuticals (USA), Inc. · $0.05185 per EA · eff. 2026-09-23 filed
  • 29300-0344-10 · Unichem Pharmaceuticals (USA), Inc. · $0.05185 per EA · eff. 2026-09-23 filed
  • 31722-0999-01 · not listed as a package in the FDA directory · $0.05185 per EA · eff. 2026-09-23 filed
  • 31722-0999-05 · not listed as a package in the FDA directory · $0.05185 per EA · eff. 2026-09-23 filed
  • 31722-0999-10 · not listed as a package in the FDA directory · $0.05185 per EA · eff. 2026-09-23 filed
  • 50268-0107-11 · not listed as a package in the FDA directory · $0.05185 per EA · eff. 2026-09-23 filed
  • 50268-0107-15 · AvPAK · $0.05185 per EA · eff. 2026-09-23 filed
  • 52817-0321-00 · TruPharma LLC · $0.05185 per EA · eff. 2026-09-23 filed
  • 52817-0321-10 · TruPharma LLC · $0.05185 per EA · eff. 2026-09-23 filed
  • 52817-0321-50 · TruPharma LLC · $0.05185 per EA · eff. 2026-09-23 filed
  • 58657-0732-01 · Method Pharmaceuticals LLC · $0.05185 per EA · eff. 2026-09-23 filed
  • 58657-0732-10 · Method Pharmaceuticals LLC · $0.05185 per EA · eff. 2026-09-23 filed
  • 58657-0932-01 · Method Pharmaceuticals LLC · $0.05185 per EA · eff. 2026-09-23 filed
  • 58657-0932-05 · Method Pharmaceuticals LLC · $0.05185 per EA · eff. 2026-09-23 filed
  • 58657-0932-10 · not listed as a package in the FDA directory · $0.05185 per EA · eff. 2026-09-23 filed
  • 59651-0395-01 · Aurobindo Pharma Limited · $0.05185 per EA · eff. 2026-09-23 filed
  • 59651-0395-05 · Aurobindo Pharma Limited · $0.05185 per EA · eff. 2026-09-23 filed
  • 59651-0395-99 · Aurobindo Pharma Limited · $0.05185 per EA · eff. 2026-09-23 filed
  • 60687-0826-01 · American Health Packaging · $0.05185 per EA · eff. 2026-09-23 filed
  • 60687-0826-11 · not listed as a package in the FDA directory · $0.05185 per EA · eff. 2026-09-23 filed
  • 62135-0474-05 · Chartwell RX, LLC · $0.05185 per EA · eff. 2026-09-23 filed
  • 62135-0474-90 · Chartwell RX, LLC · $0.05185 per EA · eff. 2026-09-23 filed
  • 70710-1286-00 · Zydus Pharmaceuticals (USA) Inc. · $0.05185 per EA · eff. 2026-09-23 filed
  • 70710-1286-01 · Zydus Pharmaceuticals (USA) Inc. · $0.05185 per EA · eff. 2026-09-23 filed
  • 70710-1286-05 · Zydus Pharmaceuticals (USA) Inc. · $0.05185 per EA · eff. 2026-09-23 filed
  • 70756-0289-11 · Lifestar Pharma LLC · $0.05185 per EA · eff. 2026-09-23 filed
  • 70756-0289-12 · Lifestar Pharma LLC · $0.05185 per EA · eff. 2026-09-23 filed
  • 70756-0289-51 · Lifestar Pharma LLC · $0.05185 per EA · eff. 2026-09-23 filed
  • 71930-0007-12 · Eywa Pharma Inc · $0.05185 per EA · eff. 2026-09-23 filed
  • 71930-0007-13 · Eywa Pharma Inc · $0.05185 per EA · eff. 2026-09-23 filed
  • 72888-0011-00 · Advagen Pharma Limited · $0.05185 per EA · eff. 2026-09-23 filed
  • 72888-0011-01 · Advagen Pharma Limited · $0.05185 per EA · eff. 2026-09-23 filed
  • 72888-0011-05 · Advagen Pharma Limited · $0.05185 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

7 other products in the NADAC file share the FDA nonproprietary name baclofen with BACLOFEN 20 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
BACLOFEN 5 MG TABLET
generic · tablet
$0.06798 per EA filed
eff. 2026-09-23
$0.18654 per EA filed
Part D 2024 average
BACLOFEN 5 MG/5 ML SOLUTION
generic · solution
$1.07017 per ML filed
eff. 2026-09-23
We don’t know yet
BACLOFEN 10 MG TABLET
generic · tablet
$0.03199 per EA filed
eff. 2026-09-23
$0.18654 per EA filed
Part D 2024 average
BACLOFEN 10 MG/5 ML SOLUTION
generic · solution
$2.04441 per ML filed
eff. 2026-09-23
We don’t know yet
BACLOFEN 15 MG TABLET
generic · tablet
$1.66662 per EA filed
eff. 2026-09-23
$0.18654 per EA filed
Part D 2024 average
BACLOFEN 20 MG TABLET this page
generic · tablet
$0.05185 per EA filed
eff. 2026-09-23
$0.18654 per EA filed
Part D 2024 average
BACLOFEN 25 MG/5 ML SUSPENSION
generic · suspension
$3.76436 to $3.78853 per ML filed
eff. 2026-09-23
We don’t know yet
FLEQSUVY 25 MG/5 ML SUSPENSION
brand · suspension
$5.98153 per ML filed
eff. 2026-09-23
$5.25798 per ML filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 47 NDCs’ NADAC prices is $0.05185 per EA filed.

Of the 7 other products in FDA’s gamma-Aminobutyric Acid-ergic Agonist class priced per EA, 4 have a higher middle NADAC price and 3 a lower one. The one in the middle is BACLOFEN 5 MG TABLET, at $0.06798 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $5.60 for 30 tablets, at an average of $0.18654 per EA in 2024 (2024-01-01 to 2024-12-31) for “Baclofen*” and “Baclofen”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 5,180,407 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

44 of the product’s 47 NDCs have this Medicare figure; the other 3 do not, and the interactive card says why for each.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for BACLOFEN 20 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Baclofen* / Baclofen: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. *: CMS says this average reflects multiple routes of administration, which may have different unit prices. Only NADAC NDCs whose FDA route includes ORAL point at this name (113 of the 127 the name join matched); NDCs of another route or with no known FDA route do not. 9 of the 113 NDCs that point at this name are not listed in the FDA NDC Directory as packages of their own; their route was taken from FDA's record for the same product (labeler and product code). 119 of 127 NADAC NDCs joined to this name are priced per EA (8 per ML): CMS's average mixes those units.